Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Using the NCDB for cancer care improvement: an introduction to available quality assessment tools.

Literature DB >> 19466738

Using the NCDB for cancer care improvement: an introduction to available quality assessment tools.

Mehul V Raval¹, Karl Y Bilimoria, Andrew K Stewart, David J Bentrem, Clifford Y Ko.

Abstract

Improving the quality of cancer care requires high-quality data, mechanisms to feed back information to hospitals, systems to act on the data, and participation of providers. The purpose of this review is to describe how the National Cancer Database (NCDB) can be utilized to improve the quality of cancer care in the United States through a variety of benchmarking reports and data feedback mechanisms available to hospitals approved by the Commission on Cancer (CoC).

Entities: Disease

Mesh：

Year: 2009 PMID： 19466738 DOI： 10.1002/jso.21173

Source DB: PubMed Journal: J Surg Oncol ISSN： 0022-4790 Impact factor: 3.454

Keyword Cloud
Cited

48 in total

1. Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis.

Authors: John R Bergquist; Tommy Ivanics; Curtis B Storlie; Ryan T Groeschl; May C Tee; Elizabeth B Habermann; Rory L Smoot; Michael L Kendrick; Michael B Farnell; Lewis R Roberts; Gregory J Gores; David M Nagorney; Mark J Truty
Journal: J Surg Oncol Date: 2016-07-20 Impact factor: 3.454

2. Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base.

Authors: Abiola Ibraheem; Olufunmilayo I Olopade; Dezheng Huo
Journal: Cancer Date: 2020-06-10 Impact factor: 6.860

3. Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes?

Authors: Colleen M Kiernan; Alexander A Parikh; Lee L Parks; Carmen C Solórzano
Journal: J Am Coll Surg Date: 2014-12-17 Impact factor: 6.113

4. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer.

Authors: Ewa Ruel; Samantha Thomas; Michaela Dinan; Jennifer M Perkins; Sanziana A Roman; Julie Ann Sosa
Journal: J Clin Endocrinol Metab Date: 2015-02-02 Impact factor: 5.958

Using the NCDB for cancer care improvement: an introduction to available quality assessment tools.

1. Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis.

2. Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base.

3. Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes?

4. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer.

5. Cytoreductive nephrectomy in the modern era: Predictors of use, morbidity, and survival.

6. The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer.

7. Outcomes of Primary Colorectal Sarcoma: A National Cancer Data Base (NCDB) Review.

8. Disease severity and radioactive iodine use for thyroid cancer.

9. Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes.

10. Laparoscopic staging for apparent stage I epithelial ovarian cancer.